Improving Weight Loss in Healthy Adults With Overweight and Obesity: An Artificial Intelligence-assisted Dietary Prediction and Prevention System With Continuous Glucose Monitoring
1 other identifier
interventional
300
1 country
1
Brief Summary
This study aims to examine the effectiveness of a novel dietary lapse prediction and prevention self-regulation app called the eating behaviour trigger-response inhibition program (eTRIP), and the addition of continuous glucose monitoring (CGM), on healthy eating and weight loss in people with overweight and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2025
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
February 9, 2026
January 1, 2026
1.4 years
June 24, 2025
January 31, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Height
Taken using a wall mounted measuring tape.
At weeks 0, 10 and 24.
Weight
Taken using InBody 120
At weeks 0, 10 and 24.
Waist Circumference
Taken using a measuring tape.
At weeks 0, 10 and 24.
BMI
Taken using InBody 120
At weeks 0, 10 and 24.
Self regulation of Eating Behaviour Questionnaire (SREBQ)
The Self-Regulation of Eating Behaviour Questionnaire (SREBQ) is a validated self-administered instrument used to assess individuals' self-regulation in relation to eating behavior. It evaluates the extent to which individuals monitor, control, and regulate their eating behaviors in everyday contexts. Higher scores indicate greater self-regulation of eating behavior.
At weeks 0, 10 and 24.
Secondary Outcomes (12)
Patient Health Questionnaire-2 (PHQ-2)
At weeks 0, 10 and 24.
Euro Quality of life 5 Dimensions-5 Levels (EQ-5D-5L)
At weeks 0, 10 and 24.
Generalized Anxiety Disorder 2-item (GAD-2)
At weeks 0, 10 and 24.
Percentage Body Fat
At weeks 0, 10 and 24.
Body Fat Mass
At weeks 0, 10 and 24.
- +7 more secondary outcomes
Study Arms (3)
eTRIP smartphone application
EXPERIMENTALIntervention group 1 involves using the eating behaviour trigger-response inhibition program(eTRIP) smartphone application for 10 weeks, where participants will need to take pictures of their food items as part of their food logging and may also engage with app-based activities to build self-regulatory skills in sticking to their weight loss plans. Additionally, participants will also apply a continuous glucose monitoring (CGM) sensor on their arm and taught how to scan the CGM sensor so that they can monitor their glucose levels for the first 10 days.
FatSecret smartphone application
SHAM COMPARATORIntervention group 2 involves using the FatSecret smartphone application for participants to monitor their calorie intake, without any continuous glucose monitoring.
Control
NO INTERVENTIONControl group will not receive any smartphone application or continuous glucose monitoring.
Interventions
Intervention group 1 involves using the eating behaviour trigger-response inhibition program(eTRIP) smartphone application for 10 weeks, where participants will need to take pictures of their food items as part of their food logging and may also engage with app-based activities to build self-regulatory skills in sticking to their weight loss plans. Additionally, participants will also apply a continuous glucose monitoring (CGM) sensor on their arm and taught how to scan the CGM sensor so that they can monitor their glucose levels for the first 10 days.
Intervention group 2 involves using the FatSecret smartphone application for participants to monitor their calorie intake, without any continuous glucose monitoring.
Eligibility Criteria
You may qualify if:
- are 21-65 years old
- have BMI ≥23 kg/m2
- can comprehend the English language
- uses a smartphone that can download apps
- are willing to perform continuous glucose monitoring (CGM) using the Dexcom continuous glucose monitoring system
- willing to travel to the National University of Singapore (NUS)
- able to provide informed consent
You may not qualify if:
- are using/intend to use other apps for weight loss;
- are pregnant or lactating (as it would affect weight change and caloric needs)
- are diagnosed severe mental disorders (e.g. major depressive disorder and schizophrenia)
- are on prescribed meal replacements or pharmacotherapy
- have serious medical conditions
- are scheduled for any kind of surgery within the next 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University of Singapore
Singapore, 117597, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 24, 2025
First Posted
February 9, 2026
Study Start
January 22, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
February 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share